Preclinical safety evaluation of the nadolol/bendroflumethiazide combination in mice, rats, and dogs.


Nadolol, a beta-adrenergic antagonist, and bendroflumethiazide, a thiazide diuretic, were administered orally alone and in combination to animals in acute and 6-month toxicity studies and in a rat teratology study. The two drugs in combination showed no evidence of potentiation of acute toxicity in mice. Nadolol and/or bendroflumethiazide were administered… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.